Hersh Ziv, Weisband Yiska Loewenberg, Bogan Ariel, Leibovich Adir, Obolski Uri, Nevo Daniel, Gilad-Bachrach Ran
Clalit Health Services, Tel-Aviv, Israel.
Clalit Research Center, Innovation Division, Clalit Health Services, Tel Aviv, Israel.
Child Adolesc Psychiatry Ment Health. 2024 Apr 15;18(1):48. doi: 10.1186/s13034-024-00736-w.
The impact of long-term Coronavirus disease 2019 (COVID-19) on the pediatric population is still not well understood. This study was designed to estimate the magnitude of COVID-19 long-term morbidity 3-6 months after the date of diagnosis.
A retrospective study of all Clalit Health Services members in Israel aged 1-16 years who tested positive for SARS-CoV-2 between April 1, 2020 and March 31, 2021. Controls, who had no previous diagnosis of COVID-19, were one-to-one matched to 65,548 COVID-19-positive children and teens, and were assigned the infection dates of their matches as their index date. Matching included age, sex, socio-economic score, and societal sector. Individuals were excluded from the study if they had severe medical conditions before the diagnosis such as cancer, diabetes, chronic respiratory diseases, and/or abnormal physiological development. Generalized Estimating Equations were used to estimate the associations between COVID-19 and the use of medical services. The analysis focused on the 3-6 months after the infection date. Adjustments were made for demographics and for the use of medical services 6-12 and 3-6 months before the infection date. The latter was necessary because of observed disparities in medical service utilization between the groups before the COVID-19 diagnosis, despite the matching process.
Statistically significant differences were only found for referrals for mental health services [adjusted relative-risk (RR) 1·51, 95%CI 1·15 - 1·96; adjusted risk-difference (RD) 0·001, 95%CI 0·0006 - 0·002], and medication prescriptions of any kind (RR 1·03, 95%CI 1·01-1·06; RD 0·01 95%CI 0·004 - 0·02).
The significant increase in medication prescriptions and mental health service referrals support the hypothesis that COVID-19 is associated with long-lasting morbidities in children and adolescents aged 1-16 years. However, the risk difference in both instances was small, suggesting a minor impact on medical services.
2019年冠状病毒病(COVID-19)对儿童群体的长期影响仍未得到充分了解。本研究旨在估计确诊日期后3至6个月COVID-19长期发病的程度。
对2020年4月1日至2021年3月31日期间在以色列所有年龄在1至16岁、SARS-CoV-2检测呈阳性的Clalit健康服务成员进行回顾性研究。对照组为未曾诊断出COVID-19的人群,与65548名COVID-19呈阳性的儿童和青少年进行一对一匹配,并将其匹配对象的感染日期指定为他们的索引日期。匹配因素包括年龄、性别、社会经济得分和社会部门。如果个体在诊断前患有严重疾病,如癌症、糖尿病、慢性呼吸道疾病和/或生理发育异常,则被排除在研究之外。使用广义估计方程来估计COVID-19与医疗服务使用之间的关联。分析重点关注感染日期后的3至6个月。对人口统计学因素以及感染日期前6至12个月和3至6个月的医疗服务使用情况进行了调整。由于在COVID-19诊断之前观察到两组之间在医疗服务利用方面存在差异,尽管进行了匹配过程,但进行后者的调整是必要的。
仅在心理健康服务转诊方面发现了具有统计学意义的差异[调整后的相对风险(RR)为1.51,95%置信区间为1.15 - 1.96;调整后的风险差异(RD)为0.001,95%置信区间为0.0006 - 0.002],以及任何类型的药物处方(RR为1.03,95%置信区间为1.01 - 1.06;RD为0.01,95%置信区间为0.004 - 0.02)。
药物处方和心理健康服务转诊的显著增加支持了COVID-19与1至16岁儿童和青少年长期发病相关的假设。然而,在这两种情况下风险差异都很小,表明对医疗服务的影响较小。